Bictegravir/emtricitabine/tenofovir alafenamide as first-line treatment in naïve HIV patients in a rapid-initiation model of care: BIC-NOW clinical trial

Autor:	Hidalgo-Tenorio, Carmen, Sequera, Sergio, Vivancos, María Jesus, Vinuesa, David, Collado, Antonio, Santos, Ignacio De Los, Sorni, Patricia, Cabello-Clotet, Noemi, Montero, Marta, Font, Carlos Ramos, Terron, Alberto, Galindo, Maria José, Martinez, Onofre, Ryan, Pablo, Omar-Mohamed, Mohamed, Albendín-Iglesias, Helena, Javier, Rosario, Ruz, Miguel Ángel López, Romero, Alberto, Garcia-Vallecillos, Coral
Zdroj:	In International Journal of Antimicrobial Agents June 2024 63(6)
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect